Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro, Jonathan Corren, Ian Pavord, +24

New England Journal of Medicine

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, +18

New England Journal of Medicine

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Sally E. Wenzel, Mario Castro, Jonathan Corren, +13

The Lancet

AsthmaPulmonary CareAllergyClinical TrialsDupilumab Efficacy +8

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Diamant Thaçi, Eric L. Simpson, Lisa A. Beck, +18

The Lancet

AllergyAtopic DermatitisAllergy MedicineModerate-to-severe Atopic DermatitisSkin Allergy +5

Conjunctivitis in dupilumab clinical trials

Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, +25

British Journal of Dermatology

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma

Jonathan Corren, Mario Castro, Thomas G. O’Riordan, +19

The Journal of Allergy and Clinical Immunology In Practice

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

William W. Busse, Jorge Máspero, Klaus F. Rabe, +13

Advances in Therapy

Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model

Xiu-Min Li, Teng-Fei Zhang, Chih-Kang Huang, +5

Journal of Allergy and Clinical Immunology

Food AllergyAllergyAllergy MedicineMedicineMurine Model +7

Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase <scp>II</scp> a open‐label trial and subsequent phase <scp>III</scp> open‐label extension

Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, +19

British Journal of Dermatology

Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma

Steven F. Weinstein, Rohit Katial, Shyamalie Jayawardena, +9

Journal of Allergy and Clinical Immunology